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RNAi: Applications in
Vertebrate Pest
Management
Katherine E. Horak 1,*
Sequence-directed inhibition of
protein synthesis by RNAi has
potential as a means to control
pest wildlife. Species specific by
design, RNAi reduces impacts on
nontarget species and the envi-
ronment. Additional research ad-
vancing the field of RNAi-based
management of vertebrate pest
wildlife is timely.
Plant scientist Richard Jorgensen first
described his observation of gene silenc-
ing in petunias in the early 1990s. Since
that time, Andrew Fire and Craig Mello
earned a Nobel Prize for their work in
nematodes and coined the phrase RNA
interference. Significant effort has been
made in human pharmaceuticals to use
RNAi in the treatment of numerous dis-
eases with the first clinical trials for an
RNAi-based human therapeutics coming
only 6 years after its discovery. The ap-
pealing attribute of RNAi is that it mediates
sequence-specific degradation of mRNA.
Therefore, RNAi is used to block the
synthesis of specific proteins (Box 1).
This is useful for disease treatment, but
also shows promise for the development
of species-specific toxicants or reproduc-
tive inhibitors for the control of animal
species. There has been significant prog-
ress applying RNAi technology for the
control of insect pests [1,2]; in 2017,
the US Environmental Protection Agency
registered the first RNAi-based product
targeting insects. Despite the potential
diverse applications of RNAi technology
in vertebrates for fertility control, invasive
species eradication, and pest species
management to protect human health
and agriculture, little progress has been
made in applying RNAi to vertebrate con-
trol.
Invasive and pest wildlife species cause
significant damage to ecosystems and
human infrastructure, spoil food stores,
and eat or ruin food crops. On average,
rodents damage or spoil 10–30% of
food crops (N77 million tons) annually,
enough food to feed 180 million people
[3]. Mitigating these effects often depends
on controlling animals using chemicals
in toxic baits or fertility control agents.
Criticism of these control methods is
often focused on lack of efficacy, risks to
nontarget species, and environmental
burden. Therefore, the development of
novel control technologiesmust be focused
on species specificity and low environ-
mental impact. Sequence-specific gene
silencing via RNAi holds promise for
effective management of pest wildlife. The
silencing of genes using RNAi can be more
cost-effective and humane with fewer non-
target effects than current approaches.
RNAi as Lethal Control
The ability to silence a single gene that is
critical to life shows significant potential
for the field of toxicant development.
Toxicants currently used to control verte-
brates often have significant effects in
nontarget animals [4]. RNAi-based toxi-
cants can be designed specifically to
the target animal’s genes, reducing risks
to nontarget species. To achieve this,
genes from the target animal are com-
pared with the gene sequences of non-
targets to identify regions of significant
divergence. RNAi molecules are then de-
signed to bind those regions of the target
animal’s gene (Figure 1). These sequence
differences result in a mismatch of the
RNAi and the mRNA of the nontarget
animal; this mismatch prevents binding
and the subsequent gene silencing. Dif-
ferences of a single nucleotide have
been shown to be sufficient to prevent
RNAi binding [5]. RNAi sequences are
approximately 21 base pairs in length so
the region to which the RNAi is designed
can be moved down the gene until a re-
gion with no similarity to nontarget spe-
cies is found. This enables researchers
to develop RNAi molecules that have ef-
fects in target species with no effects in
nontarget animals even if they are ex-
posed to RNAi.
RNAi in Rodent Eradications on
Islands
Invasive rats and mice cause significant
harm to island ecosystems by damaging
flora and causing the extinction of many
species [6]. Fortunately, after the removal
of invasive rodents, island ecosystems
can flourish; however, these rodent eradi-
cations rely on the use of anticoagulant
rodenticides and therefore pose risks to
nontarget species. RNAi-based rodenti-
cides would be an important innovation
Box 1. RNAi
RNAi is a biological mechanism that directs the post-transcriptional silencing of protein synthesis. It is an
evolutionarily conserved mechanism in eukaryotes. RNAi is dependent on a protective pathway within cells
that degrades mRNA and is thought to be evolutionarily maintained to protect against viral infections.
Double-stranded RNA (dsRNA) binds to an enzyme called DICER that cleaves the dsRNA into smaller
fragments which are then integrated into the RNA-induced silencing complex (RISC). The RISC complex is
responsible for separating the short dsRNA fragments into single-stranded segments. One of these single-
stranded segments is then shuttled to and binds the matching mRNA sequencing that was transcribed from
DNA. The complex formed by the RISC (with fragment of the initial dsRNA) and the mRNA then cleaves and
degrades the mRNA. The gene for which the mRNA coded is, therefore, not synthesized and the gene is
silenced.
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and a significant advancement for island
eradication efforts [7]. The costs associ-
ated with protecting nontarget species
from harm represent a barrier to imple-
mentation of eradications on islands
that house some of the world’s most en-
dangered species. Since RNAi-based ro-
denticides would pose little risk to
nontarget species, this technology
would enable rodent eradications on
islands previously deemed to have spe-
cies assemblages that were too complex
for cost-effective eradication efforts.
RNAi to Disrupt Fertility
Although lethal control using chemical tox-
icants is a mainstay for themanagement of
pest wildlife, inhibiting reproduction may
be an effective means to control popula-
tions and might be preferred over lethal
control in some cases. An inexpensive,
noninvasive method to sterilize animals
would be of benefit in the effort to manage
both wild horse and feral dog populations
without the use of lethal control. RNAi
could be effective as a reproductive inhibi-
tor for the control of feral animals. Silencing
the Kiss1 gene using RNAi has shown po-
tential in initial studies [8,9] and meets
many of the criteria for success. The
Kiss1 gene has limited distribution and is
found in tissues involved in reproduction.
Animals lacking Kiss1 gene products
(proteins) are infertile. Introducing RNAi for
the Kiss1 gene would block the synthesis
of the kisspeptin protein that is critical to
reproduction. The systemic delivery of
an RNAi-based reproductive inhibitor that
causes permanent sterility would help in
the nonlethal management of many wildlife
species, reducing not only the damage
they may cause to the environment and
human infrastructure but also the transmis-
sion of zoonotic diseases.
Risks and Benefits
Although RNAi is often grouped together
with gene drives in discussions of risk
[10], there are significant differences in
the technologies. Gene drives increase
the frequency of a specific gene over
time in a population through genetic mod-
ification that is passed down to offspring
[11]. RNAi molecules do not need to be in-
corporated into the genome of animals to
be efficacious. Therefore, RNAi does not
genetically modify organisms. This is an
important distinction because the hurdles
of containment associated with gene-
drive based approaches do not apply.
Risk evaluation for RNAi-based tools
(toxicants or reproductive inhibitors)
could likely follow the current paradigm
for traditional chemical toxicants. That
is, if unpredicted risk from RNAi-based
tools is found, they could be removed
from use until mitigation measures or
further technological advancements are
made. However, if current risk analysis
techniques are to be used, careful selec-
tion of delivery platforms should be made
as virally vectored RNAi tools may have
different risk profiles. The benefits of
RNAi-based tools are far reaching,
as the risks to the environment and non-
target species are minimized, allowing
for widespread use.
Concluding Remarks
Despite the potential diverse applications
of RNAi technology in vertebrates (fertility
control, invasive species eradication, and
pest species control to protect human
health and agriculture), little progress has
been made in applying RNAi to these clas-
ses of animals. A single proof-of-concept
study using RNAi to control sea lampreys
combined with recent advances in RNAi
delivery have opened the door to numer-
ous innovative applications of this technol-
ogy in vertebrate management [12]. One
of the hurdles to further development of
RNAi in vertebrates will be delivery. To
facilitate widespread use of RNAi-based
Figure 1. Pathway of RNAi Gene Silencing.(i) Double-stranded RNA fragment, 21–23 nucleotides in length
in the cytoplasm of target cell following directed delivery by carrier molecule. (ii) The guide strand and passenger
strand are separated. The passenger strand is discarded. (iii) The guide strand is incorporated into the RNA
induced silencing complex (RISC). (iv) The RISC/guide RNA complex finds the corresponding target mRNA
and binds. (v) mRNA is cleaved and degraded. The protein coded for by that mRNA is not synthesized. This is
termed gene silencing. Figure created with BioRender.com.
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products, oral baits will likely be neces-
sary. Delivering RNAi orally will face many
challenges, including protection from the
hostile conditions in the gastrointestinal
tract (GI), uptake into the systemic circula-
tion, and shuttling the RNAi to the site of
action. Research in nanotechnology has
led to the development of numerous differ-
ent nanoparticles that have been shown to
facilitate effective oral delivery and GI up-
take [13]. Other scientists are making
progress tackling cellular delivery and in-
ternalization using cell-penetrating pep-
tides [14]. Continued research in delivery,
in vivo shuttling, and cell penetration will
be imperative for the success of RNAi
technology in vertebrate pest manage-
ment applications.
Because they are species-specific by
design, RNAi-based products reduce risks
to nontarget organisms, enabling them
to be used broadly across landscapes,
even in ecosystems that historically have
been avoided because of environmental
concerns. However, the small segments
of nucleotides that make up RNAi mole-
cules may still be recognized as foreign
by both target and nontarget animals,
thereby eliciting an immune response.
These possible immune adverse effects
of RNAi will need to be considered during
RNAi development. Advances have been
made toward reducing immune activation
but continued research is important to
ensure low risks to nontarget species
[15]. Another benefit of interfering RNA
is that it does not involve modification
of the genome and consequently is not
heritable; therefore, it is free from the
controversy surrounding gene drives.
Continued research in RNAi will provide
breakthrough advancements in tools to
control animal species protecting human
health, agriculture, and infrastructure. Their
use on the landscape level will require
careful development of baits that retain
activity through exposure to the condi-
tions of the GI tract and are stable in
harsh environmental conditions of varying
temperature, humidity, and UV exposure.
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